Drug Topics e-News:
Having trouble viewing this email? View in a browser.
|
You are subscribed to %%list.name%% as %%emailaddr%%. Unsubscribe.
|
to Drug Topics e-News
|
|
|
|
 |
 |
| Newest: Osteoporosis update |
| For pharmacists, from Drug Topics: Continuing education for pharmacists and pharmacy technicians. Go to CE site here |
|
|
|
|
Survey
This month we would like to know...
To reduce 30-day readmission rates for Medicare beneficiaries, our health system:
• Uses pharmacists' medication therapy management skills in hospital-to-home transitions
• Plans to use pharmacists' medication therapy management skills in hospital-to-home transitions within 6 months
• Plans to use pharmacists' medication therapy management skills in hospital-to-home transitions within 12 months
• Has no plans in place to use pharmacists' medication therapy management skills in hospital-to-home transitions
|
|
|
FDA published an online safety communication on June 15, informing prescribers and patients that pioglitazone (Actos, Takeda Pharmaceuticals America Inc., Deerfield, Illinois) use may be associated with a 20% to 40% increased hazard of new bladder cancer. Read full article. |
 |
|
|
To confirm your e-newsletter subscription, click here.
To ensure future delivery of email newsletters from
Drug Topics, please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff
|
 |
A monthly review of the
peer-reviewed literature by
Drug Topics' Editorial Advisor
Anna D. Garrett, PharmD, BCPS. Anna Garrett is manager, Outpatient Clinical Pharmacy Programs, Mission Hospital, Asheville, N.C.
|
Risk of recurrent VTE higher in men.
Read full article.
|
Novo Nordisk recently sent a letter to healthcare professionals, reminding them about the potential risks of thyroid C-Cell tumors and acute pancreatitis associated with Victoza. Read full article. |
|
FDA announced reports of medication errors involving risperidone (Risperdal, Johnson & Johnson) and ropinirole (Requip, GlaxoSmithKline), noting that in some cases, patients who took the wrong medication needed to be hospitalized, according to a Medication Safety Announcement released June 13. Read full article. |
|
Merck & Co. has redesigned 34 of its drug container labels to improve readability and provide better information on product and strength differentiation, according to a statement on the company's website. Read full article. |
|
A new labeling system improves the syringe preparation workflow by automatically printing full-color labels compliant with American Society of Anesthesiologists and containing all The Joint Commission required elements, announced a statement issued by the manufacturer. Read full article. |
 |
Meetings and Events
June 25-28, 2011 NACDS Marketplace Conference
Boston
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
registration@nacds.org
July 22-25, 2011 NPhA Annual Convention
Atlanta
Contact:
107 Kilmayne Drive, Suite C
Cary, NC 27511
Phone: 404-262-3344
Fax: 404-262-8689
August 27-30, 2011 NACDS Pharmacy & Technology Conference
Boston
Contact:
P.O. Box 34814
Alexandria, VA 22334-0814
703-683-5678
October 6-7 NCPA Diabetes Accreditation
Standards-Practical Applications (DASPA)
Nashville, TN
Contact:
100 Daingerfield Road
Alexandria, VA 22314
800-544-7447
|
|
|
|
| Contact Us |
Contact a Drug Topics editor Click Here
Contact a Drug Topics sales representative Click Here
Learn about direct mail, reprints and classifieds in Drug Topics Click Here |
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
